What happened Shares of $DiDi Global Inc.(DIDI)$plunged 44% on Friday, following reports that the Chinese ride-hailing leader was ceasing its preparations for a listing on the Hong Kong Stock Exchange. So what DiDi reportedly went ahead with its initial public offering (IPO) in June despite calls from Chinese regulators to first strengthen its data management systems, so as to better protect its users' personal information. That decision led the Chinese government to prevent Didi from signing up new users as it conducted a review of the company's cybersecurity practices. In December, the situation worsened to the point that Didi announced its intention to delist its shares from the New York Stock Exchange. It said at the time
DIAMOND009
No personal profile
6Follow
57Followers
0Topic
0Badge
Why DiDi Stock Crashed
Why DiDi Stock Crashed
Is Nvidia Stock a Buy Now?
In late August,Nvidia(NVDA-2.08%)reported results for its fiscal second-quarter (ended July 31), and they weren't great. The company's growth slowed dramatically, and its guidance projects that to continue. Like many businesses, the challenging economic environment is taking a toll on this leadingchip manufacturerover the short term, causing volatility in the company's financials.That said, there are many reasons to be bullish on the company. The long-term opportunity for Nvidia looks bright as semiconductors are rising in popularity, and the company is still seeing success in the industries with the highest potential. Shares are down almost 49% year-to-date. Here's why that looks like a deal.Nvidia's rough quarterSecond-quarter earnings results were a significant shift compared to Nvidia'
Is Nvidia Stock a Buy Now?
$e.l.f. Beauty Inc.(ELF)$ This run on ELF has been strong! Solid earnings and fast growth, and once sentiment turned, the stock took off — watching those gains stack up feels great!
Are you asking whether there is "substantial evidence" as shown in the FDA's decision. Qualitative vs Quantitative? At least it will be over soon. having an advisory committee meeting is not a bad thing. $amlx had a same meeting and is up 80% today! bears are stealing your shares.$Amylyx Pharmaceuticals, Inc.(AMLX)$
Are you sure you know LKCO's value?
Hello guys,In this research analyst report published in 2019, yes it is old, bit it is GOLD, you will find the most compelling reason why this Luokung is worth way more than people think.Even if it was produced in 2019, the author knew that they were on the brink of acquiring EmapGo and based his projection on that. It contains the most detailed description of what their entire portfolio consists of.The projected revenue for 2021 was 300m$USD, profit 90m$USD. The financial could be off a bit, because of the pandemic and the lost of 2 contracts due to the delisting saga, of which the company mentioned in their last 20-F annual report.I personally was expecting 150m$ Revenue for 2021 after EmapGo acquisition completion, people have no idea how big they are in China.I had a projected PPS of 1
ALS incurable disease and average life expectancy is 3-5 years after diagnosis. AMLX drug is not cure butcan control disease progress and extend life expectancy. First and the only drug that can be used for ALS.After approval buyout or partnership with big pharma almost for sure.$Amylyx Pharmaceuticals, Inc.(AMLX)$
Grab to Be Fully Powered by Its Own Mapping Technology by Q3 2022
Grab Holdings Limited (NASDAQ: GRAB) today announced the launch of GrabMaps, a new enterprise service that will allow the company to tap into the US$1 billion market opportunity in Southeast Asia per year for mapping and location-based services1. First developed for in-house use, GrabMaps was created to address Grab’s need for a more hyperlocal solution to power its services.Today, GrabMaps provides location-based intelligence and services to all Grab verticals in 7 out of the 8 countries it operates in, and Grab expects to be fully self-sufficient2with GrabMaps by Q3 2022.Tan Hooi Ling, Co-founder, Grabsaid, "Grab has always sought to build innovative tech that addresses Southeast Asia’s hyperlocal needs and GrabMaps is a great example of that. The back alleys and narrow side streets comm
Here’s another concerning metric about Carnival. Their RCD, Revenue Per Cruising Day is actually above 2019, but yet they are posting massive losses. This suggests that despite higher revenue driven by on board purchases, they aren’t getting the margins they need to be profitable. This means they need to raise prices even more. So all of this talk about these cruise addicts returning is a legitimate point but what happens when they get serious sticker shock? And another part of their voyage that they’ll be getting hurt on is the airfare to the port city. Domestic flight costs are up 50% yoy! Cruising is not going away, but it is not for the middle class anymore.$Carnival(CCL)$
Micron has made three announcements within its embedded portfolio and ecosystem expansion that addresses data at the edge within the industrial and automotive markets. The first is the launch of the world's first high-capacity 1.5TB microSD available for sampling to customers. Micron is also announcing the first International Organization of Standardization (ISO) 26262 Automotive Safety Integration Level (ASIL) D certification of memory for its LPDDR5 DRAM. Micron is also adding embedded and edge computing module providers congatec and PHYTEC to its Industrial Quotient (IQ) partner program. Let's dive into these announcements and what it means for the competitive edge.$Micron Technology(MU)$
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company focused on the development, manufacture, and commercialization of complex and innovative treatments for patients battling cancer and other life-threatening diseases. Our proprietary nanotechnology platform is currently centered around the enhanced delivery of a variety of drugs using novel liposomal encapsulation technology. $Plus Therapeutics, Inc.(PSTV)$
Go to Tiger App to see more news